Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.33 EUR
Change Today +0.016 / 1.22%
Volume 400.0
SAC On Other Exchanges
As of 3:50 AM 10/7/15 All times are local (Market data is delayed by at least 15 minutes).

sanochemia pharmazeutika ag (SAC) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/24/15 - €1.79
52 Week Low
01/23/15 - €0.92
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

sanochemia pharmazeutika ag (SAC) Related Businessweek News

No Related Businessweek News Found

sanochemia pharmazeutika ag (SAC) Details

SANOCHEMIA Pharmazeutika AG, a specialty pharmaceuticals company, develops and manufactures drugs and diagnostics in the areas of neurodegeneration, pain, and oncology. It offers active pharmaceutical ingredients; sterile and semi-sterile liquid, and semi-liquid presentations, such as antibiotics and hormones; clinical diagnostics; and veterinary pharmaceuticals, as well as radiological products, including a range of X-ray imaging agents and the MRT imaging agents. The company’s products include Tolperisone, a muscle relaxant; and galantamine that is used in an Alzheimer's disease. It also researches and develops in therapeutic areas, such as painful muscle spasms/spasticity, and bladder cancer diagnostic; and offers contract manufacturing services. The company was founded in 1990 and is headquartered in Vienna, Austria.

Founded in 1990

sanochemia pharmazeutika ag (SAC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sanochemia pharmazeutika ag (SAC) Key Developments

Sanochemia Pharmazeutika AG, H1 2015 Earnings Call, May 28, 2015

Sanochemia Pharmazeutika AG, H1 2015 Earnings Call, May 28, 2015

Sanochemia Pharmazeutika AG, 2014 Earnings Call, Dec 18, 2014

Sanochemia Pharmazeutika AG, 2014 Earnings Call, Dec 18, 2014

Sanochemia Pharmazeutika AG to Report First Half, 2015 Results on May 28, 2015

Sanochemia Pharmazeutika AG announced that they will report first half, 2015 results on May 28, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAC:AV €1.33 EUR +0.016

SAC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SAC.
View Industry Companies

Industry Analysis


Industry Average

Valuation SAC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 0.4x
Price/Cash Flow 18.2x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOCHEMIA PHARMAZEUTIKA AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at